• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析临床神经学数据的方法:多发性硬化症中的促肾上腺皮质激素

Methodology for analyzing clinical neurological data: ACTH in multiple sclerosis.

作者信息

Henderson W G, Tourtellotte W W, Potvin A R, Rose A S

出版信息

Clin Pharmacol Ther. 1978 Aug;24(2):146-53. doi: 10.1002/cpt1978242146.

DOI:10.1002/cpt1978242146
PMID:209928
Abstract

From 1965 to 1968 a multicenter (USA) clinical trial was conducted to compare ACTH with placebo for the treatment of multiple sclerosis patients in a stage of acute exacerbation. Of seven evaluation systems which were used, one was a quantitative neurological examination. In this report, the quantitative neurological data have been re-evaluated using a transformation of the data which express patient scores in terms of a percentage of age- and sex-matched normal function followed by a reduction of the data into composite neurological functions vs time. The results support the positive findings of previous reports. In addition, the methodology helps to simplify the therapists' task of interpreting results by enabling him to determine how near normal function the patient came following the treatment trial.

摘要

1965年至1968年,美国进行了一项多中心临床试验,比较促肾上腺皮质激素(ACTH)与安慰剂对处于急性加重期的多发性硬化症患者的治疗效果。在使用的七个评估系统中,有一个是定量神经学检查。在本报告中,对定量神经学数据进行了重新评估,方法是对数据进行转换,以年龄和性别匹配的正常功能百分比来表示患者得分,然后将数据归纳为综合神经功能与时间的关系。结果支持了先前报告中的阳性发现。此外,该方法有助于简化治疗师解释结果的任务,使他能够确定患者在治疗试验后功能恢复到接近正常的程度。

相似文献

1
Methodology for analyzing clinical neurological data: ACTH in multiple sclerosis.分析临床神经学数据的方法:多发性硬化症中的促肾上腺皮质激素
Clin Pharmacol Ther. 1978 Aug;24(2):146-53. doi: 10.1002/cpt1978242146.
2
Training examiners to administer a quantitative neurological examination for a multicenter clinical trial.为一项多中心临床试验培训考官进行定量神经学检查。
Arch Phys Med Rehabil. 1975 Jul;56(7):289-95.
3
Cooperative study in the evaluation of therapy in multiple sclerosis; ACTH vs placebo in acute exacerbations. Preliminary report.
Neurology. 1968 Jun;18(6):Suppl:1-10. doi: 10.1212/wnl.18.6_part_2.1.
4
Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs placebo in acute exacerbation.
Trans Am Neurol Assoc. 1969;94:126-33.
5
Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.多发性硬化症治疗评估的合作研究。促肾上腺皮质激素与安慰剂——最终报告。
Neurology. 1970 May;20(5):1-59. doi: 10.1212/wnl.20.5_part_2.1.
6
A critique of steroid trials in multiple sclerosis.对多发性硬化症中类固醇试验的批判。
Neuroepidemiology. 1987;6(1-2):40-5. doi: 10.1159/000110099.
7
The use of cyclophosphamide in the treatment of multiple sclerosis.环磷酰胺在多发性硬化症治疗中的应用。
Ann N Y Acad Sci. 1984;436:373-81. doi: 10.1111/j.1749-6632.1984.tb14808.x.
8
Acute improvement in exacerbating multiple sclerosis produced by intravenous administration of mannitol.静脉注射甘露醇对多发性硬化症加重期的急性改善作用。
Ann Neurol. 1985 Oct;18(4):443-50. doi: 10.1002/ana.410180406.
9
Double-blind study of the effect of corticotropin treatment in multiple sclerosis.
Ann Med Intern Fenn. 1966;55(3):71-3.
10
[ACTH treatment of multiple sclerosis].
Duodecim. 1966;82(18):867-73.

引用本文的文献

1
Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials.多发性硬化急性复发治疗的疗效、安全性及生活质量:随机对照试验文献综述结果
Degener Neurol Neuromuscul Dis. 2019 Jul 1;9:55-78. doi: 10.2147/DNND.S208815. eCollection 2019.